1 Introduction Cancer remains a leading cause of morbidity and mortality worldwide, affecting millions of individuals each year (1). Estimates from the International Agency for Research on Cancer (IARC) report close to 20 million new cases of cancer in 2022, with an expected number of 35 million new cases by 2050 (2). As a multifactorial disease, its development and progression can be influenced by various genetic, environmental, and lifestyle factors, including diet and nutrition (3).
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Del Conte
BRAF class II-III mutations in NSCLC: a single center experience
Abstract Background: Currently, there is no consensus on the optimal treatment sequence for NSCLC patients with class II-III BRAF mutations, where standard of care implies immunochemotherapy and scarce data on targeted therapy is available. Materials and methods: This is an observational, single centre case series of 9 patients collected in a Cancer Institute in Italy diagnosed with NSCLC with a BRAF class II or III mutation between 2020 and April 2025.
Trastuzumab Deruxtecan With Nivolumab in HER2-Expressing Metastatic Breast or Urothelial Cancer: Analysis of the Phase Ib DS8201-A-U105 Study
This content is only available via PDF. This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license. This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License .
Osimertinib in Patients With Treatment-Naive EGFR-Mutant Non-small Cell Lung Cancer: Overall Survival, Post-progression Management and Budget Impact Analysis in Real-World
Lung cancer is a leading cause of cancer-related death worldwide.1 Treatment with tyrosine kinase inhibitors (TKIs) is the current standard of care in locally advanced or metastatic non-small-cell lung cancer (aNSCLC) harbouring epidermal growth factor receptor (EGFR) sensitizing mutations.2-9 Osimertinib is an oral, third-generation, irreversible EGFR-TKI that potently and selectively inhibits both EGFR-TKI-sensitizing mutations and the T790M resistance mutation,10 with high central nervous...
Távora e la conoscenza dello spazio
IdiomacatalàDeutschEnglishespañoleuskarafrançaisgalegoitalianoportuguêsromână
PED in 2024: improving the community deposition of structural ensembles for intrinsically disordered proteins
Intrinsically disordered proteins or regions (IDPs/IDRs) lack a specific, stable structure and instead exist as rapidly interconverting conformers. This arises from their relatively uniform free-energy landscape, resulting in their highly dynamic and heterogeneous nature (1). IDPs/IDRs play significant roles in various essential functions such as cell signaling, regulation and recognition.
Il circolo vizioso degli appalti in Italia
IdiomacatalàDeutschEnglishespañoleuskarafrançaisgalegoitalianoportuguêsromână
Applications of indocyanine green (ICG) fluorescence technology in open surgery: preliminary experience in pediatric surgery
Introduction Most head, neck and thorax masses occurring in children are of either inflammatory/infectious, congenital, or of neoplastic origin (1). The first ones can be the result of reactive lymphadenopathy or infectious lymphadenitis. Common congenital developmental masses include thyroglossal duct cysts, branchial cleft cysts, dermoid cysts, vascular malformations, hemangiomas, lymphangiomas or gynecomastia.
Robotic-assisted pyeloplasty in children: a systematic review of the literature
Journal of Robotic Surgery, Mar 2023 This is a preview of a remote PDF: https://link.springer.com/content/pdf/10.1007/s11701-023-01559-1.pdf Esposito, Ciro, Cerulo, Mariapina, Lepore, Benedetta, Coppola, Vincenzo, D’Auria, Daniela, Esposito, Giorgia, Carulli, Roberto, Del Conte, Fulvia, Escolino, Maria. , Journal of Robotic Surgery, 2023, pp. 1-8, DOI: 10.1007/s11701-023-01559-1
Quality of life of pediatric patients operated for pilonidal sinus disease - European Journal of Pediatrics
Abstract Quality of life (QOL) outcome is an ideal method for determining the efficacy of a surgical treatment. In children operated for pilonidal sinus disease (PSD), open procedures imply prolonged wound care, significant morbidity, and high recurrence rates. Endoscopic treatment (PEPSIT) overcomes these limitations. We report our experience in the management of PSD to evaluate the QOL of patients undergoing open and endoscopic treatment.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Del
Contact Del, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack